查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1747016

日本数位治疗市场报告（按应用（糖尿病、肥胖症、心血管疾病、中枢神经系统疾病、呼吸系统疾病、戒烟等）、最终用途（患者、提供者、付款人、雇主等）和地区）2025 年至 2033 年

Japan Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年，日本数位治疗市场规模达3.195亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到19.245亿美元，2025-2033年期间的复合年增长率（CAGR）为20.43%。关节炎、心血管併发症、糖尿病和骨质疏鬆症等各种慢性疾病的盛行率不断上升，人工智慧(AI)和机器学习(ML)的不断进步，以及清晰的指导方针和框架的日益完善，是推动市场发展的一些关键因素。

数位疗法是基于软体的干预措施，旨在透过改变患者行为和提供临床支持来带来积极的健康结果。它们包括行为疗法应用程序，专注于改变行为模式以解决压力、焦虑和忧郁等心理健康问题。它们还包括慢性病管理平台，透过药物提醒、活动追踪和个人化健康建议等功能帮助患者监测和管理自身状况。它们还包含远端患者监测，即使用穿戴式装置和感测器远端监测患者的生命征象和健康指标。它们依靠科学证据和临床试验来确保其有效性。它们通常经过严格的测试，以验证其对特定健康结果的影响。它们透过提供个人化和互动式体验来优先考虑用户参与度。它们可能包含即时回馈、进度追踪和用户友好介面等功能。数位疗法旨在补充传统的医疗保健方法。它们可以与电子健康记录 (EHR) 集成，并将患者与医疗保健提供者联繫起来，以实现无缝的护理协调。它们对术后復健、慢性病管理和老年人护理非常有用。它们透过提供便利且经济高效的解决方案来增加医疗保健的可近性。数位疗法可以提供一种比传统疗法更经济有效的替代方案。

日本数位治疗市场趋势：

目前，数位疗法透过让患者积极参与护理、持续监测和个人化干预来改善患者健康状况，因此对其需求不断增长，这是推动日本市场成长的关键因素之一。此外，关节炎、心血管併发症、糖尿病和骨质疏鬆症等各种慢性病的盛行率不断上升，推动人们采用创新有效的治疗方式。数位疗法由于能够提供个人化和远距干预，解决了慢性病日益加重的负担。此外，技术的不断进步，特别是人工智慧 (AI) 和机器学习 (ML) 领域的技术进步，使数位介入能够分析大量资料集、个人化治疗计划并不断适应个别患者的需求。穿戴式装置、感测器和其他连接装置的整合进一步增强了数位疗法收集即时健康资料的能力，为临床医生提供明智的决策依据。此外，日益转向基于价值的护理模式以及对预防性医疗保健的重视，正在加速数位疗法作为管理慢性病的经济高效策略在该国的应用。监管机构、患者和医疗保健提供者也认识到投资数位干预措施的经济效益，这些措施不仅可以治疗慢性病，还可以预防其恶化。此外，关于数位疗法审批及其融入主流医疗保健的明确指导方针和框架的持续建立，也正在支持该国市场的成长。

日本数位治疗市场细分：

应用程式洞察：

  • 糖尿病
  • 肥胖
  • 化学气相沉积
  • 中枢神经系统疾病
  • 呼吸系统疾病
  • 戒烟
  • 其他的

最终用途洞察：

  • 患者
  • 提供者
  • 付款人
  • 雇主
  • 其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本数位治疗市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本数位治疗市场有何影响？
  • 日本数位治疗市场根据应用如何划分？
  • 根据最终用途，日本数位治疗市场是如何分類的？
  • 日本数位治疗市场的价值链分为哪些阶段？
  • 日本数位疗法的主要驱动因素和挑战是什么？
  • 日本数位治疗市场的结构是怎么样的？主要参与者是谁？
  • 日本数位治疗市场的竞争程度如何？

本报告回答的关键问题：

  • 日本数位治疗市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本数位治疗市场有何影响？
  • 日本数位治疗市场根据应用如何划分？
  • 根据最终用途，日本数位治疗市场是如何分類的？
  • 日本数位治疗市场的价值链分为哪些阶段？
  • 日本数位疗法的主要驱动因素和挑战是什么？
  • 日本数位治疗市场的结构是怎么样的？主要参与者是谁？
  • 日本数位治疗市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本数位治疗市场 - 简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本数位治疗市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本数位治疗市场-细分：按应用

  • 糖尿病
    • 概述
  • 肥胖
    • 概述
  • 化学气相沉积
    • 概述
  • 中枢神经系统疾病
    • 概述
  • 呼吸系统疾病
    • 概述
  • 戒烟
    • 概述
  • 其他的

第 7 章：日本数位治疗市场 - 分裂：最终用途别

  • 患者
    • 概述
  • 提供者
    • 概述
  • 付款人
    • 概述
  • 雇主
    • 概述
  • 其他的

第八章：日本数位治疗市场－竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第九章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第十章：日本数位治疗市场-产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 11 章：附录

简介目录
Product Code: SR112025A19617

Japan digital therapeutics market size reached USD 319.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,924.5 Million by 2033, exhibiting a growth rate (CAGR) of 20.43% during 2025-2033. The growing prevalence of various chronic diseases like arthritis, cardiovascular complications, diabetes, and osteoporosis, rising advancements in artificial intelligence (AI) and machine learning (ML), and increasing establishment of clear guidelines and frameworks represent some of the key factors driving the market.

Digital therapeutics are software-based interventions designed to bring about positive health outcomes by modifying patient behavior and providing clinical support. They comprise behavioral therapy apps, which focus on modifying behavior patterns to address mental health conditions, such as stress, anxiety, and depression. They also include chronic disease management platforms, which help patients monitor and manage their conditions through features like medication reminders, activity tracking, and personalized health recommendations. They encompass remote patient monitoring, which involves the use of wearable devices and sensors to monitor the vital signs and health metrics of patients remotely. They rely on scientific evidence and clinical trials to ensure their effectiveness. They often undergo rigorous testing to validate their impact on specific health outcomes. They prioritize user engagement by providing personalized and interactive experiences. They may include features like real-time feedback, progress tracking, and user-friendly interfaces. Digital therapeutics are designed to complement traditional healthcare approaches. They can integrate with electronic health records (EHRs) and connect patients with healthcare providers for seamless coordination of care. They are useful for post-surgery recovery, chronic disease management, and eldercare. They increase access to healthcare by providing convenient and cost-effective solutions. Digital therapeutics can offer a cost-effective alternative to traditional treatments.

Japan Digital Therapeutics Market Trends:

At present, the increasing demand for digital therapeutics as they contribute to better health outcomes by actively involving patients in their care and continuously monitoring and personalized interventions represents one of the crucial factors impelling the growth of the market in Japan. Besides this, the rising prevalence of various chronic diseases like arthritis, cardiovascular complications, diabetes, and osteoporosis is driving the adoption of innovative and effective treatment modalities. Digital therapeutics addresses the increasing burden of chronic illnesses due to its ability to deliver personalized and remote interventions. In addition, the growing advancements in technology, particularly in the realms of artificial intelligence (AI) and machine learning (ML), are empowering digital interventions to analyze vast datasets, personalize treatment plans, and continuously adapt to individual patient needs. The integration of wearables, sensors, and other connected devices further enhances the capability of digital therapeutics to collect real-time health data, providing clinicians with valuable insights for informed decision-making. Apart from this, the increasing shift towards value-based care models and a focus on preventive healthcare is accelerating the adoption of digital therapeutics as a cost-efficient strategy for managing chronic conditions in the country. Regulatory bodies, patients, and healthcare providers are also recognizing the economic benefits of investing in digital interventions that not only treat but also prevent the exacerbation of chronic diseases. Additionally, the rising establishment of clear guidelines and frameworks for digital therapeutics approval and integration into mainstream healthcare is supporting the market growth in the country.

Japan Digital Therapeutics Market Segmentation:

Application Insights:

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

End Use Insights:

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan digital therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan digital therapeutics market?
  • What is the breakup of the Japan digital therapeutics market on the basis of application?
  • What is the breakup of the Japan digital therapeutics market on the basis of end use?
  • What are the various stages in the value chain of the Japan digital therapeutics market?
  • What are the key driving factors and challenges in the Japan digital therapeutics?
  • What is the structure of the Japan digital therapeutics market and who are the key players?
  • What is the degree of competition in the Japan digital therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Digital Therapeutics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Digital Therapeutics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Digital Therapeutics Market - Breakup by Application

  • 6.1 Diabetes
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Obesity
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 CVD
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 CNS Disease
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Respiratory Diseases
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)
  • 6.6 Smoking Cessation
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2019-2024)
    • 6.6.3 Market Forecast (2025-2033)
  • 6.7 Others
    • 6.7.1 Historical and Current Market Trends (2019-2024)
    • 6.7.2 Market Forecast (2025-2033)

7 Japan Digital Therapeutics Market - Breakup by End Use

  • 7.1 Patients
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Providers
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Payers
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Employers
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2019-2024)
    • 7.5.2 Market Forecast (2025-2033)

8 Japan Digital Therapeutics Market - Competitive Landscape

  • 8.1 Overview
  • 8.2 Market Structure
  • 8.3 Market Player Positioning
  • 8.4 Top Winning Strategies
  • 8.5 Competitive Dashboard
  • 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

  • 9.1 Company A
    • 9.1.1 Business Overview
    • 9.1.2 Product Portfolio
    • 9.1.3 Business Strategies
    • 9.1.4 SWOT Analysis
    • 9.1.5 Major News and Events
  • 9.2 Company B
    • 9.2.1 Business Overview
    • 9.2.2 Product Portfolio
    • 9.2.3 Business Strategies
    • 9.2.4 SWOT Analysis
    • 9.2.5 Major News and Events
  • 9.3 Company C
    • 9.3.1 Business Overview
    • 9.3.2 Product Portfolio
    • 9.3.3 Business Strategies
    • 9.3.4 SWOT Analysis
    • 9.3.5 Major News and Events
  • 9.4 Company D
    • 9.4.1 Business Overview
    • 9.4.2 Product Portfolio
    • 9.4.3 Business Strategies
    • 9.4.4 SWOT Analysis
    • 9.4.5 Major News and Events
  • 9.5 Company E
    • 9.5.1 Business Overview
    • 9.5.2 Product Portfolio
    • 9.5.3 Business Strategies
    • 9.5.4 SWOT Analysis
    • 9.5.5 Major News and Events

10 Japan Digital Therapeutics Market - Industry Analysis

  • 10.1 Drivers, Restraints, and Opportunities
    • 10.1.1 Overview
    • 10.1.2 Drivers
    • 10.1.3 Restraints
    • 10.1.4 Opportunities
  • 10.2 Porters Five Forces Analysis
    • 10.2.1 Overview
    • 10.2.2 Bargaining Power of Buyers
    • 10.2.3 Bargaining Power of Suppliers
    • 10.2.4 Degree of Competition
    • 10.2.5 Threat of New Entrants
    • 10.2.6 Threat of Substitutes
  • 10.3 Value Chain Analysis

11 Appendix